AusPAR: Retigabine

Related information

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

20 November 2013
AusPAR Details
AusPAR
AusPAR: Retigabine (pdf, 867 KB)
AusPAR: Retigabine (docx, 2 MB)
Attachment: Product Information: Retigabine (pdf, 145 KB)
Attachment: Product Information: Retigabine (docx, 54 KB)
Attachment: Extract from Clinical Evaluation Report: Retigabine (pdf, 3 MB)
Attachment: Extract from Clinical Evaluation Report: Retigabine (docx, 11 MB)
Active Ingredient
Retigabine
Product Name
Trobalt
Sponsor
GlaxoSmithKline Australia Pty Ltd
Submission Number
PM-2011-04248-3-1
Submission Type
New chemical entity
Decision
Approved
AusPAR Date
17 October 2013
Publication Date

20 November 2013
Tags: 
AusPARs
URL: 
https://www.tga.gov.au/node/939